Management of Late Anemia in Rhesus Hemolytic Disease: Use of Recombinant Human Erythropoietin (A Pilot Study)
- 1 May 1996
- journal article
- clinical trial
- Published by Springer Nature in Pediatric Research
- Vol. 39 (5) , 831-834
- https://doi.org/10.1203/00006450-199605000-00015
Abstract
Pediatric Research publishes original papers, invited reviews, and commentaries on the etiologies of diseases of children and disorders of development, extending from molecular biology to epidemiology. Use of model organisms and in vitro techniques relevant to developmental biology and medicine are acceptable, as are translational human studies.Keywords
This publication has 16 references indexed in Scilit:
- The Effect of Epoetin Beta (Recombinant Human Erythropoietin) on the Need for Transfusion in Very-Low-Birth-Weight InfantsNew England Journal of Medicine, 1994
- Suppression of erythropoiesis by intrauterine transfusions in hemolytic disease of the newborn: Use of erythropoietein to treat the late anemiaThe Journal of Pediatrics, 1993
- Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurityThe Journal of Pediatrics, 1991
- Recombinant human erythropoietin in the anemia of prematurity: Results of a placebo-controlled pilot studyThe Journal of Pediatrics, 1991
- Effects of intravascular, intrauterine transfusion on prenatal and postnatal hemolysis and erythropoiesis in severe fetal isoimmunizationThe Journal of Pediatrics, 1990
- Red cell volume and cardiac output in anaemic preterm infants.Archives of Disease in Childhood, 1990
- Effects of recombinant human erythropoietin in infants with the anemia of prematurity: A pilot studyThe Journal of Pediatrics, 1990
- Late hyporegenerative anemia in Rh hemolytic diseaseThe Journal of Pediatrics, 1989
- Neutropenia and thrombocytopenia in infants with Rh hemolytic diseaseThe Journal of Pediatrics, 1989
- Circulating Erythroid Progenitors in the Anemia of PrematurityNew England Journal of Medicine, 1987